A study using local epidemiological and economic data found that vaccinating children 1-14 years old in high-risk slum areas in Dhaka, Bangladesh using a locally-produced oral cholera vaccine provided through periodic campaigns would be a highly cost-effective means of controlling endemic cholera — reducing cholera incidence in the entire population by 45% over 10 years and costing US$440-635 per DALY averted. Vaccinating all persons aged one and above would reduce incidence much further (by 91%) but would be less cost-effective.
Full Citation:
Khan AI, Levin A, Chao DL, DeRoeck D et al.. 2018. The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis. PLoS NTD. 12(10).
Title of Article: The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis
Author(s): Khan AI, Levin A, Chao DL, DeRoeck D et al.
Publication Year: 2018
Publication Name: PLoS NTD
Publication Volume: 12(10)
Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/30300420/
DOI (Digital Object Identifier): 10.1371/journal.pntd.0006652
Topics: Economics & Return on Investment
Disease Vaccines: Cholera | Diarrhea
Countries: Bangladesh
WHO Regions: South-East Asia